Institution statistics

UNIVERSITATSKLINIKUM ERLANGEN - DE 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 29
As coordinator: 3
As participant: 21
Sole participant: 5
Coordinator / Participant Ratio: 0.14*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 1.487.231 8.999.999 2.372.944 1 2
2019 16.534.333 42.704.763 5.988.629 3 3
2018 0 3.000.000 103.750 1
2017 171.461 9.928.915 1.134.894 1 2
2016 0 21.666.437 778.722 3
2015 1.479.781 24.868.647 2.255.615 1 3
2012 11.109.056 3.227.975 2.224.174 2 1
2011 0 2.779.000 234.956 1
2010 0 52.002.335 1.942.480 5
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
KAROLINSKA INSTITUTE5
UNIVERSITY OF GLASGOW5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG4
MEDIZINISCHE UNIVERSITAET WIEN4
STICHTING KATHOLIEKE UNIVERSITEIT4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
ACADEMISCH ZIEKENHUIS GRONINGEN3
ACADEMISCH ZIEKENHUIS LEIDEN3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI3
ISTITUTO SUPERIORE DI SANITA3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
PFIZER LIMITED3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSITAET ZUERICH3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY OF NEWCASTLE UPON TYNE3
AMGEN LIMITED2
ASTELLAS PHARMA EUROPE BV2
ASTON UNIVERSITY2
ASTRAZENECA AB2
BAYER PHARMA2
BOC ASSET MANAGEMENT2
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER2
DEPARTMENT OF HEALTH2
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
HEALTH PROTECTION AGENCY2
INSERM TRANSFERT2
INSTITUT CATALA DE LA SALUT2
INSTITUT GUSTAVE ROUSSY2
JANSSEN PHARMACEUTICA NV2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KING'S COLLEGE LONDON2
LVIVSKYI NATIONALNYI MEDYCHNYI UNIVERSYTET IMENI DANYLA HALYTSKOHO2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU2
NOVARTIS PHARMA2
PHILIPPS UNIVERSITAET MARBURG2
REDOXIS AB2
SANOFIAVENTIS DEUTSCHLAND2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
SEMMELWEIS EGYETEM2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TARTU ULIKOOL2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
THE UNIVERSITY OF NOTTINGHAM2
UNIVERSITAET DES SAARLANDES2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF SURREY2
UNIVERSITY OF TURKU2
VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA2
ABBVIE1
ABBVIE INC1
ACTELION PHARMACEUTICALS1
ALGOE1
AMGEN1
ANOCCA AB1
APITOPE INTERNATIONAL NV1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA UK LIMITED1
ATHINAEREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS TON EPIKOINONION KAI TIS GNOSIS1
AWE PLC1
AYUNTAMIENTO DE ASPARRENA1
BALKANIKA ENERGY AD1
BAYER AKTIENGESELLSCHAFT1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOCRATES LIFE SCIENCES1
BIOGAZELLE1
BIOMAY1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIONTECH RNA PHARMACEUTICALS1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRISTOLMYERS SQUIBB COMPANY CORP1
BRUNEL UNIVERSITY LONDON1
BUNDESAMT FUER STRAHLENSCHUTZ1
BUNDESMINISTERIUM FUER WIRTSCHAFT FAMILIE UND JUGEND1
CELERA CORPORATION1
CELLPHENOMICS1
CENTRE HOSPITALIER DE L'UNIVERSITEDE MONTREAL1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CENTRO NACIONAL DE INVESTIGACIONESCARDIOVASCULARES CARLOS III1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CHU HOPITAUX DE BORDEAUX1
COCHLEAR RESEARCH AND DEVELOPMENT LIMITED1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE1
COVENTRY UNIVERSITY1
CSL BEHRING1
DANMARKS TEKNISKE UNIVERSITET1
DEMCO INSURANCE1
Constancy:

Total number of partners:439

Partner loyalty:
Frequent Partner: (> 2 projects): 71
Rare Partner: 368

Frequent / Rare Partner Ratio: 0.19

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES8
RTD HORIZONTAL TOPICS3
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-01-01RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. RESCUERparticipant6.000.00015
2020-01-01Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. NeutroCureparticipant2.999.9997
2020-01-01Breaking the barrier: How inflammation spreads from skin to joint BARRIER BREAKcoordinator1.487.2311
2019-10-01PancREatic Cancer OrganoiDs rEsearch Network PRECODEcoordinator3.992.89215
2019-07-01The role of protein degradation in FBXO11-related intellectual disability Degradation_IDcoordinator174.8061
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89734
2019-04-01Advancing osteoporosis medicine by observing bone microstructure and remodelling using a four-dimensional nanoscope 4-D nanoSCOPEcoordinator12.366.6354
2019-01-01Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities EUPHORIAparticipant2.314.3155
2019-01-01Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. ONCOBIOMEparticipant14.994.55118
2018-01-01Infradev - European Paediatric Translational Research Infrastructure ID-EPTRIparticipant3.000.00029
2017-11-01Research School for TINnitus Assessment, Causes and Treatments TIN-ACTparticipant3.928.91515
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-02-01The Viral Genome Associated Proteome VGAPcoordinator171.4611
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-01-01Pathogen and Graphene PANGparticipant580.5009
2015-11-01European AIDS Vaccine Initiative 2020 EAVI2020participant22.948.02226
2015-07-01Reactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils. REDOXITparticipant144.0004
2015-05-01Sorting of Self SOScoordinator1.479.7811
2015-03-01ORganizational Behaviour improvement for Energy Efficient adminisTrative public offices OrbEEtparticipant1.776.62510
2012-08-01Influence of protein prenylation and its modulation on the immune system Pren-IBDcoordinator167.3901
2012-06-01OSTEOIMMUNE - Unraveling the Interactions between the Immune System and Bone OSTEOIMMUNEparticipant3.227.97512
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1coordinator10.941.66538
2011-12-01Intelligent Knowledge Platform for Personal Health Monitoring Services eHealthMonitorparticipant2.779.00011
2010-10-01Post-infectious immune reprogramming and its association with persistence and chronicity of respiratory allergic diseases PreDictaparticipant5.991.60013
2010-01-01Discovery and preclinical development of new generation tuberculosis vaccines NEWTBVACparticipant11.996.73035
2010-01-01Systems biology towards novel chronic kidney disease diagnosis and treatment SysKIDparticipant11.789.53429
2010-01-01Low Dose Research towards Multidisciplinary Integration DoReMiparticipant12.999.99938
2010-01-01ADIPOSE DERIVED STROMAL CELLS FOR OSTEOARTHRITIS ADIPOAparticipant9.224.47212
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum